B Osterwalder

7.1k total citations · 2 hit papers
73 papers, 4.7k citations indexed

About

B Osterwalder is a scholar working on Hematology, Oncology and Surgery. According to data from OpenAlex, B Osterwalder has authored 73 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Hematology, 29 papers in Oncology and 12 papers in Surgery. Recurrent topics in B Osterwalder's work include Hematopoietic Stem Cell Transplantation (21 papers), Colorectal Cancer Treatments and Studies (16 papers) and Cancer Treatment and Pharmacology (16 papers). B Osterwalder is often cited by papers focused on Hematopoietic Stem Cell Transplantation (21 papers), Colorectal Cancer Treatments and Studies (16 papers) and Cancer Treatment and Pharmacology (16 papers). B Osterwalder collaborates with scholars based in Switzerland, United States and United Kingdom. B Osterwalder's co-authors include T. Griffin, Aman U. Buzdar, Hans Ulrich Burger, Chris Twelves, Stephen E. Jones, Paulo M. Hoff, Jean A. Maroun, Walter Kocha, Bruno Reigner and Joanne L. Blum and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

B Osterwalder

70 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comparison of Oral Capecitabine Versus Intravenous Fluorouracil Plus Leucovorin as First-Line Treatment in 605 Patients With Metastatic Colorectal Cancer: Results of a Randomized Phase III Study

2001 882 citations Paulo M. Hoff, Jean A. Maroun et al. profile →
Multicenter Phase II Study of Capecitabine in Paclitaxel-Refractory Metastatic Breast Cancer

1999 655 citations Stephen E. Jones, B Osterwalder et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
B Osterwalder Switzerland	24	3.8k	967	830	700	588	73	4.7k
Shenhong Wu United States	35	2.9k 0.8×	1.7k 1.7×	716 0.9×	435 0.6×	424 0.7×	96	5.5k
Michael A. Savin United States	26	1.8k 0.5×	716 0.7×	246 0.3×	620 0.9×	430 0.7×	61	3.0k
Jeffrey Crawford United States	38	5.0k 1.3×	2.0k 2.1×	587 0.7×	347 0.5×	357 0.6×	108	6.8k
Noriaki Sawada Japan	11	2.5k 0.7×	735 0.8×	301 0.4×	531 0.8×	517 0.9×	20	3.0k
Ullrich Graeven Germany	34	2.9k 0.8×	1.1k 1.1×	165 0.2×	426 0.6×	781 1.3×	135	4.4k
Jacob J. Lokich United States	35	1.9k 0.5×	1.3k 1.3×	263 0.3×	290 0.4×	961 1.6×	156	4.0k
P. Kosmidis Greece	39	3.9k 1.0×	2.3k 2.4×	191 0.2×	817 1.2×	1.0k 1.8×	224	6.4k
N Le Bail France	12	4.7k 1.2×	1.4k 1.4×	328 0.4×	331 0.5×	1.1k 1.9×	23	5.5k
Vincent J. Picozzi United States	32	3.2k 0.8×	951 1.0×	262 0.3×	699 1.0×	792 1.3×	130	4.5k
Isabelle Tabah-Fisch France	13	3.7k 1.0×	1.0k 1.1×	232 0.3×	332 0.5×	902 1.5×	23	4.6k

Countries citing papers authored by B Osterwalder

Since Specialization

Citations

This map shows the geographic impact of B Osterwalder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Osterwalder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Osterwalder more than expected).

Fields of papers citing papers by B Osterwalder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B Osterwalder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Osterwalder. The network helps show where B Osterwalder may publish in the future.

Co-authorship network of co-authors of B Osterwalder

This figure shows the co-authorship network connecting the top 25 collaborators of B Osterwalder. A scholar is included among the top collaborators of B Osterwalder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B Osterwalder. B Osterwalder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Aapro, Matti, Agustí Barnadas, Robert Leonard, et al.. (2009). What is the impact of antithrombotic therapy and risk factors on the frequency of thrombovascular events in patients with metastatic breast cancer receiving epoetin beta?. European Journal of Cancer. 45(17). 2984–2991. 9 indexed citations

Aapro, Matti, B Osterwalder, Armin Scherhag, & Hans-Ulrich Burger. (2009). Epoetin-β treatment in patients with cancer chemotherapy-induced anaemia: the impact of initial haemoglobin and target haemoglobin levels on survival, tumour progression and thromboembolic events. British Journal of Cancer. 101(12). 1961–1971. 37 indexed citations

Mekhail, Tarek, Thomas Olencki, Thomas E. Hutson, et al.. (2007). Phase II trial of capecitabine and rHu-interferon-α-2a in patients with metastatic renal cell carcinoma, limited efficacy, and moderate toxicity. Urologic Oncology Seminars and Original Investigations. 25(1). 46–52. 6 indexed citations

Crown, John, Véronique Dièras, Manfred Kaufmann, et al.. (2002). Chemotherapy for metastatic breast cancer–report of a European expert panel. The Lancet Oncology. 3(12). 719–727. 64 indexed citations

Cassidy, Jim, Chris Twelves, Eric Van Cutsem, et al.. (2002). First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous5-fluorouracil/leucovorin. Annals of Oncology. 13(4). 566–575. 422 indexed citations

O’Shaughnessy, Joyce, Joanne L. Blum, Vladimir Moiseyenko, et al.. (2001). Randomized, open-label, phase II trial of oral capecitabine (Xeloda®) vs. a reference arm of intravenous CMF (cyclophosphamide, methotrexate and 5-fluorouracil) as first-line therapy for advanced/metastatic breast cancer. Annals of Oncology. 12(9). 1247–1254. 258 indexed citations

Vasey, P., L. Pronk, Chris Twelves, et al.. (1997). Phase I and pharmacokinetic study of XelodaTM (capecitabine) in combination with docetaxel. European Journal of Cancer. 33. S246–S246. 3 indexed citations

Reusser, P, et al.. (1989). Kinetics of cytomegalovirus IgG antibody following infusion of a hyperimmune globulin preparation in allogeneic marrow transplant recipients.. PubMed. 4(3). 267–72. 6 indexed citations

Kiss, Tímea, et al.. (1988). [Bacillus subtilis infections].. PubMed. 77(45). 1219–23. 3 indexed citations

10.

Osterwalder, B, Aloïs Gratwohl, P Reusser, André Tichelli, & B Speck. (1988). Hematological Support in Patients Undergoing Allogenetic Bone Marrow Transplantation. Recent results in cancer research. 108. 44–52. 3 indexed citations

11.

Reusser, P, B Osterwalder, Haran Burri, & B Speck. (1987). Autoimmune Hemolytic Anemia Associated with IgA – Diagnostic and Therapeutic Aspects in a Case with Long-Term Follow-Up. Acta Haematologica. 77(1). 53–56. 14 indexed citations

12.

Osterwalder, B, et al.. (1987). [Simultaneous occurrence of hemophilia A and acute lymphatic leukemia].. PubMed. 117(46). 1828–31. 2 indexed citations

13.

Tichelli, André, Aloïs Gratwohl, Roland H. Wenger, et al.. (1987). ABO-incompatible bone marrow transplantation: in vivo adsorption, an old forgotten method.. PubMed. 19(6). 4632–7. 11 indexed citations

14.

Osterwalder, B, Aloïs Gratwohl, C Nissen, & B Speck. (1986). Immunoadsorption for removal of anti-A and anti-B blood group antibodies in ABO-incompatible bone marrow transplantation. Annals of Hematology. 53(5). 379–390. 19 indexed citations

15.

Osterwalder, B, Aloïs Gratwohl, C Nissen, et al.. (1985). [Invasive pulmonary aspergillosis--a diagnostic and therapeutic problem in patients with severe aplastic anemia].. PubMed. 115(11). 378–80. 5 indexed citations

16.

Niederwieser, Dietger, Aloïs Gratwohl, M. Oberholzer, et al.. (1983). Bone marrow cell dose and kinetics of recovery following allogeneic marrow transplantation in man. Annals of Hematology. 47(6). 355–360. 14 indexed citations

17.

Speck, B, Aloïs Gratwohl, B Osterwalder, et al.. (1983). [Bone marrow transplantation in acute lymphatic leukemia during the first remission].. PubMed. 113(40). 1440–1. 1 indexed citations

18.

Jeannet, M, Aloïs Gratwohl, Georg Pongratz, et al.. (1983). IMMUNOLOGIC REACTIVITY IN MARROW GRAFT RECIPIENTS RECEIVING CYCLOSPORINE TO PREVENT GRAFT-VERSUS-HOST DISEASE. Transplantation. 36(2). 125–129. 5 indexed citations

19.

Speck, B, et al.. (1982). Allogeneic marrow transplantation for chronic granulocytic leukemia. Annals of Hematology. 45(4). 237–242. 26 indexed citations

20.

Degrémont, A, et al.. (1981). [Clinical and therapeutic study of a group of 217 patients with intestinal giardiasis and amebiasis].. PubMed. 111(52). 2039–46. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact